• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并症对非ST段抬高型心肌梗死(NSTEMI)患者预后影响的评估:一项叙述性综述

Assessment of the Impact of Comorbidities on Outcomes in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients: A Narrative Review.

作者信息

Felix Bryan, Aldoohan Fawaz, Kadirage Hansanee U, Keelathara Sajeev Sethulakshmi, Kayani Maryam, Hag Saeed Mohamed Abdelsalam Ibrahim, Vempatapu Sruthi, Nasim Khadija, Pendem Harini, Armenta Annia P, Nazir Zahra

机构信息

Medical Student, Avalon University School of Medicine, Los Angeles, USA.

Internal Medicine, American Academy of Research and Academics, Delaware, USA.

出版信息

Cureus. 2024 Jul 28;16(7):e65568. doi: 10.7759/cureus.65568. eCollection 2024 Jul.

DOI:10.7759/cureus.65568
PMID:39192929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11348641/
Abstract

Non-ST-segment elevation myocardial infarction (NSTEMI) is associated with significant morbidity and mortality, occurring when the heart's need for oxygen cannot be met. It is defined by elevated cardiac biomarkers without ST-segment elevation and often carries a poorer prognosis than most ST-segment elevation events. NSTEMI usually results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus/atheromatous material. Patients with NSTEMI often have multiple comorbidities, which can worsen their prognosis and complicate treatment. This study aims to investigate the impact of comorbidities such as hypertension (HTN), diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), obesity, dyslipidemia, and smoking on patients with NSTEMI. The prevalence of each comorbidity is examined individually within the NSTEMI population to provide a clearer picture of how frequently these conditions co-occur with NSTEMI and how they affect the established NSTEMI treatment protocols.  This paper sheds light on the interaction between NSTEMI and commonly associated comorbidities through a comprehensive literature review and data analysis. This is critical for optimizing clinical decision-making and enhancing patient care, ultimately improving outcomes in this high-risk patient population.

摘要

非ST段抬高型心肌梗死(NSTEMI)与显著的发病率和死亡率相关,当心脏的氧气需求无法得到满足时就会发生。它由心肌生物标志物升高且无ST段抬高来定义,其预后通常比大多数ST段抬高事件更差。NSTEMI通常由严重冠状动脉狭窄、短暂闭塞或血栓/动脉粥样硬化物质的微栓塞引起。NSTEMI患者常伴有多种合并症,这会使他们的预后恶化并使治疗复杂化。本研究旨在调查高血压(HTN)、糖尿病(DM)、慢性阻塞性肺疾病(COPD)、肥胖、血脂异常和吸烟等合并症对NSTEMI患者的影响。在NSTEMI人群中分别检查每种合并症的患病率,以便更清楚地了解这些病症与NSTEMI同时出现的频率以及它们如何影响既定的NSTEMI治疗方案。本文通过全面的文献综述和数据分析,揭示了NSTEMI与常见相关合并症之间的相互作用。这对于优化临床决策和加强患者护理至关重要,最终改善这一高危患者群体的治疗结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/ec7a5dda845b/cureus-0016-00000065568-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/ea50363b4c99/cureus-0016-00000065568-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/78ffefd6e98f/cureus-0016-00000065568-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/b33c195df989/cureus-0016-00000065568-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/ec7a5dda845b/cureus-0016-00000065568-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/ea50363b4c99/cureus-0016-00000065568-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/78ffefd6e98f/cureus-0016-00000065568-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/b33c195df989/cureus-0016-00000065568-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ec/11348641/ec7a5dda845b/cureus-0016-00000065568-i04.jpg

相似文献

1
Assessment of the Impact of Comorbidities on Outcomes in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients: A Narrative Review.合并症对非ST段抬高型心肌梗死(NSTEMI)患者预后影响的评估:一项叙述性综述
Cureus. 2024 Jul 28;16(7):e65568. doi: 10.7759/cureus.65568. eCollection 2024 Jul.
2
Contemporary NSTEMI management: the role of the hospitalist.当代非ST段抬高型心肌梗死的管理:住院医师的作用。
Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20.
3
Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry.比较有 ST 段抬高和非 ST 段抬高心肌梗死病史的慢性冠状动脉综合征患者的长期结局:来自 TIGRIS 登记研究的结果。
BMJ Open. 2023 Dec 18;13(12):e070237. doi: 10.1136/bmjopen-2022-070237.
4
Optical coherence tomography analysis of lesion characteristics and thrombus types in non ST-segment elevation myocardial infarction patients.非 ST 段抬高型心肌梗死患者病变特征及血栓类型的光相干断层成像分析。
Int J Cardiovasc Imaging. 2024 Jul;40(7):1401-1411. doi: 10.1007/s10554-024-03071-5. Epub 2024 Jun 6.
5
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.东京都地区ST段抬高型和非ST段抬高型心肌梗死的当前特征与管理:来自东京CCU网络注册队列研究
Heart Vessels. 2016 Nov;31(11):1740-1751. doi: 10.1007/s00380-015-0791-9. Epub 2016 Jan 12.
6
Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.急性心肌梗死:FAST-MI 项目(1995 年至 2015 年法国急性 ST 段抬高或非 ST 段抬高心肌梗死注册研究)20 年来患者特征、治疗方法的变化和 6 个月预后
Circulation. 2017 Nov 14;136(20):1908-1919. doi: 10.1161/CIRCULATIONAHA.117.030798. Epub 2017 Aug 27.
7
Comparison of Clinical Outcomes after Non-ST-Segment and ST-Segment Elevation Myocardial Infarction in Diabetic and Nondiabetic Populations.糖尿病和非糖尿病人群中非ST段抬高型与ST段抬高型心肌梗死临床结局的比较
J Clin Med. 2022 Aug 29;11(17):5079. doi: 10.3390/jcm11175079.
8
Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.慢性肾脏病患者行新一代药物洗脱支架置入术后 ST 段抬高型和非 ST 段抬高型心肌梗死的两年结局。
Catheter Cardiovasc Interv. 2022 Mar;99(4):1022-1037. doi: 10.1002/ccd.30049. Epub 2021 Dec 28.
9
Coronary plaque rupture with subsequent thrombosis typifies the culprit lesion of non-ST-segment-elevation myocardial infarction, not unstable angina: non-ST-segment-elevation acute coronary syndrome study.冠状动脉斑块破裂伴随后续血栓形成是非ST段抬高型心肌梗死而非不稳定型心绞痛的罪犯病变特征:非ST段抬高型急性冠状动脉综合征研究。
Heart Vessels. 2017 Mar;32(3):241-251. doi: 10.1007/s00380-016-0862-6. Epub 2016 Jun 21.
10
Patients with no significant lesions in coronary arteries and ST-segment elevation myocardial infarction have worse outcome than patients with non-ST-segment elevation myocardial infarction: analysis from PL-ACS Registry.无冠状动脉显著病变和 ST 段抬高型心肌梗死患者的预后比非 ST 段抬高型心肌梗死患者更差:来自 PL-ACS 注册研究的分析。
Kardiol Pol. 2010 Nov;68(11):1211-7.

引用本文的文献

1
Door-to-Balloon Time and Clinical Outcome of Patients Presenting with ST-Segment Elevation Myocardial Infarction During on and off Hours: a Single Center Study.ST段抬高型心肌梗死患者在工作时间和非工作时间的门球时间及临床结局:一项单中心研究
Med Arch. 2025;79(3):172-180. doi: 10.5455/medarh.2025.79.172-180.
2
Hybrid rotational atherectomy and shockwave-assisted complex left main PCI with mechanical support in a high-bleeding risk patient, a rare case report.高出血风险患者行杂交旋磨术与冲击波辅助的复杂左主干经皮冠状动脉介入治疗并给予机械支持:一例罕见病例报告
Int J Surg Case Rep. 2025 Jun;131:111386. doi: 10.1016/j.ijscr.2025.111386. Epub 2025 May 1.

本文引用的文献

1
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.急性 ST 段抬高型心肌梗死与非 ST 段抬高型心肌梗死患者的血管紧张素受体-脑啡肽酶抑制剂治疗。
J Am Coll Cardiol. 2024 Mar 5;83(9):904-914. doi: 10.1016/j.jacc.2024.01.002.
2
Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis.超重患者代谢综合征与心肌梗死的关系:系统评价和荟萃分析。
BMC Public Health. 2024 Feb 12;24(1):444. doi: 10.1186/s12889-024-17707-7.
3
Smoking and Unstable Plaque in Acute Coronary Syndrome: A Systematic Review of The Role of Matrix Metalloproteinases.
吸烟与急性冠状动脉综合征不稳定斑块:基质金属蛋白酶作用的系统评价。
Int J Med Sci. 2023 Feb 13;20(4):482-492. doi: 10.7150/ijms.79889. eCollection 2023.
4
Impact of medications on outcomes in patients with acute myocardial infarction and chronic obstructive pulmonary disease: A nationwide cohort study.药物对急性心肌梗死合并慢性阻塞性肺疾病患者预后的影响:一项全国性队列研究。
J Chin Med Assoc. 2023 Feb 1;86(2):183-190. doi: 10.1097/JCMA.0000000000000835. Epub 2022 Oct 28.
5
Patterns of Dyslipidemia Among Acute Coronary Syndrome (ACS) Patients at a Tertiary Care Hospital in Lahore, Pakistan.巴基斯坦拉合尔一家三级护理医院急性冠状动脉综合征(ACS)患者的血脂异常模式。
Cureus. 2022 Dec 10;14(12):e32378. doi: 10.7759/cureus.32378. eCollection 2022 Dec.
6
Obesity and Coronary Artery Disease: An Updated Systematic Review 2022.肥胖与冠状动脉疾病:2022年最新系统评价
Cureus. 2022 Sep 23;14(9):e29480. doi: 10.7759/cureus.29480. eCollection 2022 Sep.
7
Epidemiological Characteristics and Risk Factors Associated with Acute Myocardial Infarction in Somalia: A Single-Center Experience.索马里急性心肌梗死的流行病学特征及相关危险因素:单中心经验
Int J Gen Med. 2022 Sep 30;15:7605-7617. doi: 10.2147/IJGM.S383690. eCollection 2022.
8
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.慢性阻塞性肺疾病对 COVID-19 大流行期间 ST 段抬高型心肌梗死患者短期预后的影响:来自国际多中心 ISACS-STEMI 注册研究的结果。
Respir Res. 2022 Aug 15;23(1):207. doi: 10.1186/s12931-022-02128-0.
9
Invasive Management for Non-ST-Segment-Elevation Myocardial Infarction and Chronic Kidney Disease: Does One Size Fit All?非ST段抬高型心肌梗死与慢性肾脏病的侵入性治疗:一种方法适用于所有人吗?
J Am Heart Assoc. 2022 Jun 17;11(12):e026390. doi: 10.1161/JAHA.122.026390.
10
The burden and risks of emerging complications of diabetes mellitus.糖尿病新并发症的负担和风险。
Nat Rev Endocrinol. 2022 Sep;18(9):525-539. doi: 10.1038/s41574-022-00690-7. Epub 2022 Jun 6.